Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Market Cap	29.35M
Revenue (ttm)	16.14M
Net Income (ttm)	-28.87M
Shares Out	1.05B
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	168,000
Average Volume	168,170
Open	0.0290
Previous Close	n/a
Day's Range	0.0280 - 0.0290
52-Week Range	0.0280 - 0.1150
Beta	n/a
RSI	38.83
Earnings Date	Oct 29, 2025

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theranostics treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima...

• Industry: Medical Laboratories
• Founded: 2011
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 9G2

Financial Performance

In 2024, SGXC:9G2's revenue was 16.65 million, an increase of 2.54% compared to the previous year's 16.23 million. Losses were -37.45 million, 107.2% more than in 2023.